reviewThe LancetNov 1, 2007Closed access

Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials

RCRobin ChristensenPKPernelle Kruse KristensenEMElse Marie BartelsHBHenning BliddalAAArne Astrup

Frederiksberg Hospital · University of Copenhagen · +1 more institution

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

1,078
total citations
FWCI
65.14
Percentile
100%
References
52
Citations per year

Authors

5

Topics & keywords

Topics
Keywords
  • Rimonabant
  • Medicine
  • Placebo
  • Adverse effect
  • Meta-analysis
  • Internal medicine
  • Weight loss
  • Psychiatry
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding